Therapeutic Antibody Monitoring

High-precision detection of therapeutic antibody concentration and functional properties alongside their dynamic changes enables therapeutic antibody monitoring of both therapeutic antibodies and anti-drug antibodies (ADA). The integration of near-infrared microarray protein chip technology enables our comprehensive support in biologics efficacy evaluation, personalized patient management, and drug development. Monitoring therapeutic antibody serum levels (e.g., adalimumab's minimum effective concentration<10 ng/mL) and ADA neutralizing activity (IC50 determination) enables prediction of treatment response, dosing optimization, and early detection of immunogenicity risks.